T-CELL LYMPHOMA
Clinical trials for T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough blood cancers: experimental drug PRT2527 enters human testing
Disease control CompletedThis early-stage trial tested a new drug called PRT2527, alone or combined with other drugs (zanubrutinib or venetoclax), in 86 people with blood cancers that returned or didn't respond to standard treatments. The main goals were to check safety, find the best dose, and see if th…
Matched conditions: T-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
New hope for Hard-to-Treat lymphoma? drug targets cancer even when marker is low
Disease control CompletedThis study tested a drug called brentuximab vedotin in 23 people with a rare type of T-cell lymphoma that had stopped responding to or returned after prior chemotherapy. The drug is designed to seek out and kill cancer cells that have a specific marker called CD30, even when leve…
Matched conditions: T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Deepa Jagadeesh • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC
-
New treatment shows promise for rare skin lymphoma in chinese patients
Disease control CompletedThis study looked at the long-term side effects and effectiveness of a drug called brentuximab vedotin in 10 Chinese adults with a rare type of skin lymphoma (CD30-positive cutaneous T-cell lymphoma). Participants received the drug through a vein every 21 days for up to 16 cycles…
Matched conditions: T-CELL LYMPHOMA
Phase: PHASE4 • Sponsor: Takeda • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC